Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 267

1.

Does Postural Awareness Contribute to Exercise-induced Improvements in Neck Pain Intensity? A Secondary Analysis of a Randomized Controlled Trial Evaluating Tai Chi and Neck Exercises.

Lauche R, Wayne PM, Fehr J, Stumpe C, Dobos G, Cramer H.

Spine (Phila Pa 1976). 2017 Jan 31. doi: 10.1097/BRS.0000000000002078. [Epub ahead of print]

PMID:
28146026
2.

ECMO for Pediatric Lung Transplantation.

Olsen MC, Anderson MJ, Fehr JJ, Christensen JL, Shepard MP, Poe JB, Eghtesady P.

ASAIO J. 2017 Jan 23. doi: 10.1097/MAT.0000000000000534. [Epub ahead of print]

PMID:
28125461
3.

Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients.

Sekaggya-Wiltshire C, von Braun A, Scherrer AU, Manabe YC, Buzibye A, Muller D, Ledergerber B, Gutteck U, Corti N, Kambugu A, Byakika-Kibwika P, Lamorde M, Castelnuovo B, Fehr J, Kamya MR.

J Antimicrob Chemother. 2017 Jan 19. pii: dkw534. doi: 10.1093/jac/dkw534. [Epub ahead of print]

PMID:
28108678
4.

Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis.

von Braun A, Sekaggya-Wiltshire C, Scherrer AU, Magambo B, Kambugu A, Fehr J, Castelnuovo B.

AIDS Res Ther. 2017 Jan 5;14(1):1. doi: 10.1186/s12981-016-0128-5.

5.

Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000-2016: a systematic review and meta-analysis.

Ghisla V, Scherrer AU, Nicca D, Braun DL, Fehr JS.

Infection. 2016 Dec 22. doi: 10.1007/s15010-016-0975-y. [Epub ahead of print]

PMID:
28005195
6.

Reduction of neonicotinoid insecticide residues in Prairie wetlands by common wetland plants.

Main AR, Fehr J, Liber K, Headley JV, Peru KM, Morrissey CA.

Sci Total Environ. 2017 Feb 1;579:1193-1202. doi: 10.1016/j.scitotenv.2016.11.102.

PMID:
27914641
7.

Prescription of Postexposure Prophylaxis for HIV-1 in the Emergency Room: Correct Transmission Risk Assessment Remains Challenging.

Marzel A, Heinrich H, Schilliger L, Fehr JS, Günthard HF, Kouyos R, Rampini SK.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):359-366. doi: 10.1097/QAI.0000000000001265.

PMID:
27906766
8.

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.

Bachofner JA, Valli PV, Kröger A, Bergamin I, Künzler P, Baserga A, Braun D, Seifert B, Moncsek A, Fehr J, Semela D, Magenta L, Müllhaupt B, Terziroli Beretta-Piccoli B, Mertens JC.

Liver Int. 2016 Sep 28. doi: 10.1111/liv.13256. [Epub ahead of print]

PMID:
27678216
9.

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.

Wang Q, De Luca A, Smith C, Zangerle R, Sambatakou H, Bonnet F, Smit C, Schommers P, Thornton A, Berenguer J, Peters L, Spagnuolo V, Ammassari A, Antinori A, Quiros-Roldan E, Mussini C, Miro JM, Konopnicki D, Fehr J, Campbell MA, Termote M, Bucher HC; Hepatitis Coinfection and Non Hodgkin Lymphoma project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord..

Ann Intern Med. 2017 Jan 3;166(1):9-17. doi: 10.7326/M16-0240.

PMID:
27750294
10.

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.

Cain LE, Caniglia EC, Phillips A, Olson A, Muga R, Pérez-Hoyos S, Abgrall S, Costagliola D, Rubio R, Jarrín I, Bucher H, Fehr J, van Sighem A, Reiss P, Dabis F, Vandenhende MA, Logan R, Robins J, Sterne JA, Justice A, Tate J, Touloumi G, Paparizos V, Esteve A, Casabona J, Seng R, Meyer L, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration..

Medicine (Baltimore). 2016 Oct;95(41):e5133.

11.

Thiol-Ene Modified Amorphous Carbon Substrates: Surface Patterning and Chemically Modified Electrode Preparation.

McKenas CG, Fehr JM, Donley CL, Lockett MR.

Langmuir. 2016 Oct 4. [Epub ahead of print]

PMID:
27657877
12.

Evaluation of a Technology-Based Adaptive Learning and Prevention Program for Stress Response-A Randomized Controlled Trial.

Wesemann U, Kowalski JT, Jacobsen T, Beudt S, Jacobs H, Fehr J, Büchler J, Zimmermann PL.

Mil Med. 2016 Aug;181(8):863-71. doi: 10.7205/MILMED-D-15-00100.

PMID:
27483525
13.

Emergency Information Forms for Children With Medical Complexity: A Simulation Study.

Abraham G, Fehr J, Ahmad F, Jeffe DB, Copper T, Yu F, White AJ, Auerbach M, Schnadower D.

Pediatrics. 2016 Aug;138(2). pii: e20160847. doi: 10.1542/peds.2016-0847.

PMID:
27436504
14.

The Effects of Tai Chi and Neck Exercises in the Treatment of Chronic Nonspecific Neck Pain: A Randomized Controlled Trial.

Lauche R, Stumpe C, Fehr J, Cramer H, Cheng YW, Wayne PM, Rampp T, Langhorst J, Dobos G.

J Pain. 2016 Sep;17(9):1013-27. doi: 10.1016/j.jpain.2016.06.004.

PMID:
27345663
15.

Challenges in achieving a target international normalized ratio for deep vein thrombosis among HIV-infected patients with tuberculosis: a case series.

Sekaggya C, Nalwanga D, Von Braun A, Nakijoba R, Kambugu A, Fehr J, Lamorde M, Castelnuovo B.

BMC Hematol. 2016 Jun 4;16:16. doi: 10.1186/s12878-016-0056-6.

16.

Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country.

Stucki D, Ballif M, Egger M, Furrer H, Altpeter E, Battegay M, Droz S, Bruderer T, Coscolla M, Borrell S, Zürcher K, Janssens JP, Calmy A, Mazza Stalder J, Jaton K, Rieder HL, Pfyffer GE, Siegrist HH, Hoffmann M, Fehr J, Dolina M, Frei R, Schrenzel J, Böttger EC, Gagneux S, Fenner L.

J Clin Microbiol. 2016 Jul;54(7):1862-70. doi: 10.1128/JCM.00126-16.

17.

Simulation-Based Assessment of ECMO Clinical Specialists.

Fehr JJ, Shepard M, McBride ME, Mehegan M, Reddy K, Murray DJ, Boulet JR.

Simul Healthc. 2016 Jun;11(3):194-9. doi: 10.1097/SIH.0000000000000153.

PMID:
27093507
18.

Summer camp, boot camp, and the formation of a new fellow.

Fehr JJ, Kuan C.

Paediatr Anaesth. 2016 May;26(5):466-7. doi: 10.1111/pan.12890. No abstract available.

PMID:
27059415
19.

Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape.

Fehr J, Nicca D, Goffard JC, Haerry D, Schlag M, Papastamopoulos V, Hoepelman A, Skoutelis A, Diazaraque R, Ledergerber B.

Infection. 2016 Aug;44(4):521-9. doi: 10.1007/s15010-016-0887-x.

PMID:
26983974
20.

Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study.

Elzi L, Conen A, Patzen A, Fehr J, Cavassini M, Calmy A, Schmid P, Bernasconi E, Furrer H, Battegay M.

Open Forum Infect Dis. 2016 Feb 1;3(1):ofw022. doi: 10.1093/ofid/ofw022.

Items per page

Supplemental Content

Support Center